Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study
E. Kissling, F. Pozo, S. Buda, I. Martinez-Baz, S. Buda, A.M. Vilcu, L. Domegan, C. Mazagatos, F. Dijkstra, N. Latorre-Margalef, S.K. Filipović, A. Machado, M. Lazar, I. Casado, R. Dürrwald, S. van der Werf, J. O'Donnell, J.A.L. Dopido, A. Meijer, M. Riess, V.V. Vučina, A.P. Rodrigues, M.E. Mihai, J. Castilla, L. Goerlitz, A. Falchi, J. Connell, D. Castrillejo, M. Hooiveld, A. Carnaha, M. Ilić, R. Guiomar, A. Ivanciuc, M. Maurel, A. Omokanye, M. Valenciano, study I-MOVE teamTijdschriftartikel
